CutisPharma is the industry leader in bringing innovation to the pharmaceutical compounding market. We aim to achieve the transformation of prescription compounding with high-quality products manufactured under strict compliance standards that increase the accuracy, quality, and efficiency of compounded prescriptions dispensed to patients.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/02/15 | $20,000,000 |
Ampersand Ventures | undisclosed |
